IXIFI

Swiss trademark · 727271 · Word mark · In force

Register entry

Registration number
727271
Application number
78867/2018
Status
In force
Type
Word mark
Filed
Sep 19, 2018
Registered
Feb 14, 2019
Published
Feb 14, 2019
Protected until
Sep 19, 2028
Language of procedure
German
Source
Swissreg

Goods and services

Pharmaceuticals

Rezeptpflichtige pharmazeutische Präparate für die Behandlung von Autoimmunerkrankungen und -störungen.

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Jun 27, 2024

    Agent removed

    Representative
    BOVARD SA, Conseils en propriété intellectuelle, Optingenstrasse 16, 3013 Berne (removed)

    Published in Swissreg on 27.06.2024

  2. Jun 27, 2024

    Agent entered

    Representative
    E. Blum & Co. AG, Hofwiesenstrasse 349, 8050 Zürich

    Published in Swissreg on 27.06.2024

  3. Aug 23, 2023

    Agent removed

    Representative
    E. Blum & Co. AG, Patent- und Markenanwälte VSP, Vorderberg 11, 8044 Zürich (removed)

    Published in Swissreg on 23.08.2023

  4. Aug 23, 2023

    Agent entered

    Representative
    BOVARD SA, Conseils en propriété intellectuelle, Optingenstrasse 16, 3013 Berne

    Published in Swissreg on 23.08.2023

  5. Aug 23, 2023

    Holder’s address changed

    Owner
    Pfizer Inc., 235 East 42nd Street, New York, NY 10017, USA → Pfizer Inc., 66 Hudson Boulevard East, New York, NY 10001-2192, USA

    Published in Swissreg on 23.08.2023

  6. Feb 14, 2019

    Registered

    Published in Swissreg on 14.02.2019

Parties

Holder

Pfizer Inc.

66 Hudson Boulevard East, New York, NY 10001-2192, US

Agent

E. Blum & Co. AG

Hofwiesenstrasse 349, 8050 Zürich

The register names each party by name and address. A party is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.